John O Agwunobi
CIK 1627893 · Chairman and CEO · last filed 2026-07-22
John O Agwunobi is a Chairman and CEO who has filed 56 SEC Form 4 insider transactions across 5 companies since 2014. The most recent filing shows the insider sold $67.1K of ENSG on Jul 22, 2026. Across all open-market trades the lifetime net is +$312.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.35M
5
56
$312.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENSG | Director | 9,503 | $183.94 | $1.75M | -$262.2K | 20 | 2026-07-22 |
| bluebird bio, Inc. (BLUE) Delisted | Director | 1,245 | $4.97 | $6.2K | $0 | 10 | 2025-06-03 |
| HLF | Chairman and CEO | 134,745 | $11.52 | $1.55M | $574.5K | 16 | 2022-05-11 |
| NKTR | Director | 618 | $74.86 | $46.3K | $0 | 3 | 2018-05-25 |
| MAGELLAN HEALTH INC (MGLN) Delisted | Director | 3,150 | $94.99 | $299.2K | $0 | 2 | 2015-05-22 |
Recent Filings
56 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-22 | ENSG | Sell (S) | −392 | -$67.1K | EDGAR |
| 2026-07-20 | ENSG | Notice (144) | −392 | -$67.1K | EDGAR |
| 2026-07-17 | ENSG | Grant (A) | +600 | $0 | EDGAR |
| 2026-04-22 | ENSG | Sell (S) | −392 | -$78.4K | EDGAR |
| 2026-04-20 | ENSG | Notice (144) | −392 | -$78.4K | EDGAR |
| 2026-04-17 | ENSG | Grant (A) | +600 | $0 | EDGAR |
| 2026-01-22 | ENSG | Sell (S) | −392 | -$70.3K | EDGAR |
| 2026-01-21 | ENSG | Notice (144) | −146 | -$26.0K | EDGAR |
| 2026-01-20 | ENSG | Notice (144) | −246 | -$44.2K | EDGAR |
| 2026-01-20 | ENSG | Grant (A) | +600 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.